M Coleman
About
In The Last Decade
M Coleman
18 papers receiving 445 citations
Peers
Comparison fields: 5 of 66
- Surgery 164
- Pulmonary and Respiratory Medicine 116
- Oncology 94
- Metals and Alloys 79
- Materials Chemistry 76
Countries citing papers authored by M Coleman
This map shows the geographic impact of M Coleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Coleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Coleman more than expected).
Fields of papers citing papers by M Coleman
This network shows the impact of papers produced by M Coleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Coleman. The network helps show where M Coleman may publish in the future.
Co-authorship network of co-authors of M Coleman
This figure shows the co-authorship network connecting the top 25 collaborators of M Coleman. A scholar is included among the top collaborators of M Coleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Coleman. M Coleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 98 | |
| 3 | The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer. | 64 |
| 4 | 73 | |
| 5 | 6 | |
| 6 | Phase I-II trial of mitoxantrone in acute leukemia. | 45 |
| 7 | Therapy for chronic myelogenous leukemia in blast crisis with etoposide and 5-azacitidine administered by continuous infusion: a Cancer and Leukemia group B Study. | 7 |
| 8 | 1 | |
| 9 | Phase II study of AMSA in patients with metastatic breast cancer: a Cancer and Leukemia Group B study. | 4 |
| 10 | Phase II trial of spirogermanium in breast adenocarcinoma: a Cancer and Leukemia Group B Study. | 2 |
| 11 | 5-azactidine and zorubicin for patients with previously treated acute nonlymphocytic leukemia: a Cancer and Leukemia Group B pilot study. | 5 |
| 12 | 8 | |
| 13 | 40 | |
| 14 | 1 | |
| 15 | 13 | |
| 16 | 5 | |
| 17 | 98 | |
| 18 | Effect of nicotinamide administration in a patient with an extrapyramidal movement disorder and hyperuricemia: a double-blind crossover study. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.